Non-Hodgkin’s Lymphoma (NHL) Information Center
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Non-Hodgkin’s Lymphoma Information Center has current, evidence-based information for you. Get the facts about non-Hodgkin’s lymphoma early detection, treatment, and survivorship, and stay up to date with ongoing non-Hodgkin’s lymphoma research that could impact your treatment decisions through our daily cancer news.
You are not alone—The CancerConnect Non-Hodgkin’s Lymphoma Community is the leading Social Media Application for Non-Hodgkin’s Lymphoma patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller... Defitelio® Approved for Life-Threatening Complication of Stem Cell Transplant
The United States Food and Drug Administration (FDA) has approved Defitelio® (defibrotide... Crafting a Better T Cell for Immunotherapy
New technology, not yet tested in humans, aims to reduce patients’ waiting time,...
CancerConnect non-Hodgkin’s lymphoma news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to lymphoma Understanding Osteonecrosis of the Jaw
Cancer and its treatment can come with a variety of complications, some more serious... What is Radioimmunotherapy (RIT) Treatment of NHL?
Radioimmunotherapy (RIT) is a type of targeted therapy that delivers radiation directly...
Non-Hodgkin’s Lymphoma Management
Sean Swarner is a master of setting a goal and achieving it. So when he... Moving Bodies, Changing Lives
Moving On Aerobics helps women regain joy of movement and physical fitness after... Where Kids Can Be Kids… And Cancer Takes a Back Seat
Cancer camps for kids provide fun and camaraderie for children facing down a cancer...
Non-Hodgkin’s Lymphoma Clinical Trials
COGANHL01P1 – A Pilot study to determine the Toxicity of the addition of Rituximab to the Inducation and Consolidation phases and the Addition of Rasburicase to the Reduction Phase in Children with Newly Diagnosed Advanced B-cell leukemia/lymphoma treated with LMB/FAB Therapy
SeaGenMarinerStudy – A Randomized Phase IIb Placebo-controlled study of R-ICE Chemotherapy (RItuximab, Ifosfamide, Carboplatin, and Etoposide) with and without SGN-40 (anti-CD40 humanized monoclonal antibody) for second-line treatment of patients with diffuse large B-cell lymphoma (DLBCL)
114-NH-301 – Phase III, Randomized, Double-blind Study of Glaiximab in combination with Rituximab compared with Rituximab in Combination with Placebo for the Treatment of Subjects with Relapsed or Refractory, Follicular Non-Hodgkin’s Lymphoma.